AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
Lamivudine, Tenofovir Disoproxil Fumarate in Rwanda
1 product registered with RDA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE-300 /300 | Rwanda FDA-HMP-MA-0080 | CELLTRION, INC./KOREA | active | 5 Aug 2026 |
Lamivudine, Tenofovir Disoproxil Fumarate — RDA Registration Details
RDA (Rwanda) has 1 registered product containing Lamivudine, Tenofovir Disoproxil Fumarate, of which 1 is currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track Lamivudine, Tenofovir Disoproxil Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.